Welcome to the wonderful and exciting world of medical devices, or maybe, more precisely, welcome to the wonderful and exciting world of medical devices marketed in the European Union.
Perhaps you’re new to the medical device market, or simply new to the medical device market in the European Union. Maybe you are new to quality management or a seasoned veteran of the Quality System Regulations (QSR) but still feel there are elements of these new regulations you don’t fully understand or aren’t sure how to best implement them.
In all of these cases this is the right program for you.
Any experienced quality person in the medical device realm already knows a lot of the topics included in these regulations, but there are some new key features.
EU-MDR 2017/745 introduces new, generally more rigorous requirements, including:
- Reclassification of some device types according to risk, contact duration, and invasiveness;
- More rigorous processes for gathering and assessing clinical evidence for high risk and implantable devices;
- Additional safety and performance requirements for many device types;
- More rigorous analysis and reporting requirements for products that contain restricted substances;
- More explicit requirements for linking Post-Market Surveillance and Post-Market Clinical Follow-up across product lifecycle closing the loop back to risk management;
- Unique Device Identification (UDI);
- Establishment of public database, EUDAMED, to include entities, products, vigilance, and clinical trials; and
- Increased responsibility & oversight by EU Authorised Representative acting on behalf of non-EU manufacturers.
The program consists of this introductory module and a further 10 modules addressing the regulations chapter by chapter.
EUMDR Training Course Modules:
- EU MDR 2017-745 Introductory Module
- EU MDR 2017-745 Module 1 Chapter I – Scope and Definitions
- EU MDR 2017-745 Module 2 Chapter II – Marketing Devices, Economic Operators
- EU MDR 2017-745 Module 3 Chapter III – Devices
- EU MDR 2017-745 Module 4 Chapter IV – Notified Bodies
- EU MDR 2017-745 Module 5 Chapter V – Classification and Conformity Assessment
- EU MDR 2017-745 Module 6 Chapter VI – Clinical Evaluation & Clinical Investigation
- EU MDR 2017-745 Module 7 Chapter VII – PMS
- EU MDR 2017-745 Module 8 Chapter VIII – Cooperation
- EU MDR 2017-745 Module 9 Chapter IX – Confidentiality, Data Protection, Funding & Penalties
- EU MDR 2017-745 Module 10 Chapter X – Final Provisions
Course Description
EU MDR 2017-745 Introductory Module
We advise you to take each course in sequence to gain an overall understanding of the regulations, however, each course can be taken as a standalone course to serve as a refresher when required. At the very least, we would encourage you to read this Introductory Module prior to embarking on any of the subsequent detailed, focused modules which delve, in-depth, into the regulations.
This module is an introductory module to explain how, why and when the new regulations have come into force, what they consist of and some of the new and strengthened features.
We will look at some of the historical events that have occurred over a period of decades and their consequences, and we will be able to see the triggers for changes in legislation and understand what brought these changes about.
This module includes a high-level overview of the contents of EU MDR 2017/745, some of the new features, the timelines for compliance and we’ll take a look at how the new MDRs compare to MDD.
EU MDR 2017-745 Module 1 Chapter I – Scope and Definitions
There are only four articles in this chapter. Articles 3 and 4 are comparatively short so naturally we shall spend the bulk of the time in this module examining Articles 1 and 2.
In this module, we will cover Article 1 – the Subject Matter and Scope, which sets out what this regulation applies to as well as what this regulation does NOT apply to. We shall also examine where a decision is required to determine which set of regulations (other than EU MDR 2017/745) a product is governed by.
We will also cover Article 2 – Definitions which set out a list of 71 definitions of devices or groups of devices which apply for the purposes of this regulation. Many of the definitions should be known to workers in the medical device industry and are given in the section “Commonly Understood Definitions”. It is not our intention to walk through all of the definitions in this module but, rather, focus on some of the more notable ones.
EU MDR 2017-745 Module 2 Chapter II – Marketing Devices, Economic Operators
This Chapter expands on some of the definitions given in Chapter I and introduces activities to be undertaken by Economic Operators before a product is placed on the market, when it is placed on the market and after it is placed on the market in the European Union.
We shall also be looking at claims which impact labelling, instructions for use (IFUs) and advertising and, potentially, classification.
There are 20 articles in this chapter including harmonized standards and common specifications and more information about the requirements for:
- Implant card and information to be supplied to the patient with an implanted device;
- EU Declaration of Conformity (DoC) & CE Marking of Conformity;
- Single-Use Devices and their reprocessing;
- Devices for special purposes;
- Systems and Procedure Packs; and
- Parts and Components.
EU MDR 2017-745 Module 3 Chapter III – Devices
Welcome to EU MDR 2017/745 – Module 3 –Chapter III – Identification and traceability of devices, Registration of Devices and of Economic Operators, Summary of Safety and Clinical Performance, European Database on Medical Devices.
There are 10 articles in this chapter: articles 25 through to 34 inclusive. Articles 25, 26, 28 and 34 are comparatively short so naturally we shall spend the bulk of the time in this module examining the other six articles.
EU MDR 2017-745 Module 4 Chapter IV – Notified Bodies
Welcome to Module 4 – EU MDR 2017/745 – Chapter IV – Notified Bodies.
This training module entails a full review of the role of a Notified Body and how it interfaces with other regulatory bodies including Member States Authorities Responsible for Notified Bodies, The EU Commission and The Medical Device Coordination Group (MDCG).
There are sixteen Articles in this chapter: Articles 35 through to 50 inclusive. Articles 37, 38, 40, 41, 43, 49 and 50 are comparatively short so naturally we shall spend the bulk of the time in this module examining the other nine Articles.
EU MDR 2017-745 Module 5 Chapter V – Classification and Conformity Assessment
Welcome to EU MDR 2017/745 – Module 5 – Chapter V – Classification and Conformity Assessment.
There are ten articles in this Chapter V (articles 51 through to 60 inclusive) and in this module we’ll look more closely at the specific details in the regulation surrounding some of the key topics discussed.
There are seven distinct areas –
- Classification of Devices (Art. 51);
- Conformity Assessment: covering Conformity Assessment Procedures (Art. 52), and The Involvement of the Notified Body in Conformity Assessments (Art. 53);
- Class III & Class IIb Devices: covering Clinical Evaluation Consultation (Art. 54), and the Mechanism for Scrutiny of Conformity Assessments (Art. 55);
- Certificate of Conformity: covering the Certificate of Conformity (Art. 56), and the Electronic system on Notified Bodies and the Certificate of Conformity (Art. 57);
- Voluntary change of Notified Body (Art. 58);
- Derogation from the conformity assessment (Art. 59); and
- Certificate of Sale (Art. 60).
EU MDR 2017-745 Module 6 Chapter VI – Clinical Evaluation & Clinical Investigation
Welcome to EU MDR 2017/745 – Module 6 – Chapter VI – Clinical Evaluation and Clinical Investigations.
This is a significant and exciting chapter introducing a life-cycle approach to ongoing CE Marking compliance; it is a process, not a project. One output of the clinical evaluation process is demonstrating clinical performance of the medical device, i.e. demonstrating that the device performs as intended and has benefit to patients. Clinical data in support of performance can come from many sources including: clinical literature, trials, usability, post-market clinical follow-up (PMCF), the state-of-the-art, and/or from “equivalent” devices.
In this module we shall study some of the new approaches and challenges to accepted approaches in the medical device industry introduced in Chapter VI.
There are 22 articles in this chapter where the majority fall under the requirements for conducting Clinical Investigations (CI) as depicted in Figure 1. In this module we’ll consider the requirements for:
- Clinical Evaluation;
- Clinical Investigations (CIs);
- Informed Consent;
- Different subject types participating in CIs; and
- The process for the execution of, management of and communication about CIs.
EU MDR 2017-745 Module 7 Chapter VII – PMS
Welcome to EU MDR 2017/745 – Module 7 –Chapter VII – Post-Market Surveillance, Vigilance and Market Surveillance.
In this module, we will look more closely at the specific details in the regulation surrounding some of the key topics discussed under this chapter of the regulation.
There are eighteen articles in this chapter: articles 83 through to 100 inclusive. Articles 84, 85, 88 and 90 are comparatively short so naturally we shall spend the bulk of the time in this module examining the other fourteen articles.
There are three sections to this chapter –
- Post-market surveillance (Articles 83 to 86);
- Vigilance (Articles 87 to 90); and
- Market surveillance (Articles 91 to 100).
EU MDR 2017-745 Module 8 Chapter VIII – Cooperation
Welcome to EU MDR 2017/745 – Module 8 –Chapter VIII – cooperation between Member States, Medical Device Coordination Group, Expert Laboratories, Expert Panels and Device Registrars.
In this module, we will look more closely at the specific details in the regulation surrounding some of the key topics discussed under this chapter of the regulation.
There are eight articles in this chapter: articles 101 through to 108 inclusive. Articles 101, 102, 104, 107 and 108 are comparatively short so naturally we shall spend the bulk of the time in this module examining the other three articles.
There are four sections to this chapter:
- Member States (Articles 101 and 102);
- Support (Articles 103 to 106);
- Conflicts of interest (Article 107) and
- Device registration and databanks (Article 108).
EU MDR 2017-745 Module 9 Chapter IX – Confidentiality, Data Protection, Funding & Penalties
Welcome to Module 9 – EU MDR 2017/745 – Chapter IX – Confidentiality, Data Protection, Funding and Penalties.
In this module we will look more closely at the specific details in the regulation surrounding some of the key topics discussed under this chapter of the regulation.
There are five articles in this chapter: Articles 109 through to 113 inclusive. A relatively short module considering the content.
The scope of this training module entails a full review of the aspects relating to Confidentiality, Data Protection and the costs associated with Funding and Penalties for non-compliance as they may arise.
EU MDR 2017-745 Module 10 Chapter X – Final Provisions
Welcome to Module 10 – EU MDR 2017/745 – Chapter X – Final Provisions.
There are ten articles in this chapter: Articles 114 through to 123 inclusive. In spite of the number of articles, this is a relatively short module considering the content, with most of the articles being quite brief.
This training module entails a review of the requirements that have to be in place prior to fully implementing EU MDR 2017/745.
There are four sections to this chapter:
- Committee Procedures (Article 114);
- Delegation (Articles 115 and 116);
- Amendments (Articles 117 to 119); and
- Stages on Introduction (Articles 120 to 123).
